for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Ligand Sees FY 2020 Earnings Per Share Of $3.62

Feb 27 (Reuters) - Ligand Pharmaceuticals Inc:

* LIGAND RAISES 2020 FINANCIAL GUIDANCE DUE TO HIGHER CAPTISOL MATERIAL SALES

* SEES FY 2020 EARNINGS PER SHARE $3.62

* SEES FY 2020 REVENUE ABOUT $133 MILLION

* MATERIAL SALES FOR 2020 ARE NOW EXPECTED TO BE APPROXIMATELY $40 MILLION

* LIGAND - SEEING PARTNERS INCREASE ORDERS IN SUPPORT OF CLINICAL STUDIES OF REMDESIVIR, WHICH IS BEING ACTIVELY ASSESSED FOR TREATMENT OF CORONAVIRUS

* UPDATED FINANCIAL GUIDANCE FOR 2020 CONTINUES TO INCLUDE CONTRIBUTION FROM CORE ASSETS AND BUSINESS OF ICAGEN Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up